{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:21:08Z","timestamp":1790968868022,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"am","delay-in-days":306,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K08AA029714"],"award-info":[{"award-number":["K08AA029714"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K08 DA058052"],"award-info":[{"award-number":["K08 DA058052"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K08 DA061258"],"award-info":[{"award-number":["K08 DA061258"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K12DA041449"],"award-info":[{"award-number":["K12DA041449"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.drugalcdep.2025.112685","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T02:53:27Z","timestamp":1745290407000},"page":"112685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Substance-induced mental disorders and discontinuation of medication for opioid use disorder"],"prefix":"10.1016","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4178-0720","authenticated-orcid":false,"given":"Alyssa Shell","family":"Tilhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8191-6875","authenticated-orcid":false,"given":"Richard A.","family":"Grucza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6595-695X","authenticated-orcid":false,"given":"Kevin Y.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2025.112685_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.addbeh.2018.11.008","article-title":"Relapse after inpatient substance use treatment: a prospective cohort study among users of illicit substances","volume":"90","author":"Andersson","year":"2019","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2025.112685_bib2","first-page":"1","article-title":"Discussing the concept of substance-induced psychosis (SIP)","author":"Bramness","year":"2024","journal-title":"Psychol. Med."},{"key":"10.1016\/j.drugalcdep.2025.112685_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.112535","article-title":"Sex disparities in outcome of medication-assisted therapy of opioid use disorder: nationally representative outpatient clinic data","volume":"267","author":"Butelman","year":"2025","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.drugalcdep.2025.112685_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23708","article-title":"Changes in buprenorphine and methadone supplies in the US during the COVID-19 pandemic","volume":"5","author":"Chen","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.drugalcdep.2025.112685_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109192","article-title":"Trends in pharmacy-based dispensing of buprenorphine, extended-release naltrexone, and naloxone during the COVID-19 pandemic by age and sex\u2013United States, March 2019\u2013December 2020","volume":"232","author":"Cremer","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112685_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/da.20918","article-title":"The effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial","volume":"29","author":"Davis","year":"2012","journal-title":"Depress Anxiety"},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112685_bib7","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.socscimed.2004.06.052","article-title":"Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials","volume":"60","author":"Donald","year":"2005","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.drugalcdep.2025.112685_bib8","first-page":"53","article-title":"Implementing dual-diagnosis services for clients with severe mental illness","author":"Drake","year":"2003","journal-title":"Dual Diagn. Publ. Online"},{"key":"10.1016\/j.drugalcdep.2025.112685_bib9","article-title":"Barriers and facilitators to substance use disorder treatment: an overview of systematic reviews","volume":"16","author":"Farhoudian","year":"2022","journal-title":"Subst. \u2370Abus."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112685_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/1471-2458-10-632","article-title":"Neighborhood socioeconomic status, Medicaid coverage and medical management of myocardial infarction: atherosclerosis risk in communities (ARIC) community surveillance","volume":"10","author":"Foraker","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.drugalcdep.2025.112685_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108244","article-title":"The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder","volume":"216","author":"Friesen","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112685_bib12","first-page":"126","article-title":"Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic","volume":"43","author":"Gelkopf","year":"2006","journal-title":"Isr. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112685_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/15504263.2020.1726549","article-title":"Depression and outcomes of methadone and buprenorphine treatment among people with opioid use disorders: a literature review","volume":"16","author":"Ghabrash","year":"2020","journal-title":"J. Dual Diagn."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112685_bib14","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.addbeh.2013.11.022","article-title":"Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses","volume":"39","author":"Goldner","year":"2014","journal-title":"Addict. Behav."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112685_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0376-8716(95)01134-K","article-title":"The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample","volume":"39","author":"Grant","year":"1995","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112685_bib16","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","article-title":"Prevalence and co-occurrence of substance use disorders and independentmood and anxiety disorders: results from the national epidemiologic survey on alcohol and relatedconditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112685_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/YCO.0b013e3283523dcc","article-title":"Comorbidity of psychiatric and substance use disorders in the United States: current issues and findings from the NESARC","volume":"25","author":"Hasin","year":"2012","journal-title":"Curr. Opin. Psychiatry"},{"issue":"11","key":"10.1016\/j.drugalcdep.2025.112685_bib18","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00127-015-1088-0","article-title":"The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings","volume":"50","author":"Hasin","year":"2015","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112685_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.psych.60.110707.163456","article-title":"A tale of two systems: co-occurring mental health and substance abuse disorders treatment for adolescents","volume":"60","author":"Hawkins","year":"2009","journal-title":"Annu Rev. Psychol."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112685_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.psychres.2014.11.077","article-title":"Primary and substance-induced psychotic disorders in methamphetamine users","volume":"226","author":"Hides","year":"2015","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112685_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jsat.2014.08.006","article-title":"Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenance","volume":"48","author":"Jaremko","year":"2015","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.drugalcdep.2025.112685_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.drugalcdep.2018.12.030","article-title":"Co-occurring substance use and mental disorders among adults with opioid use disorder","volume":"197","author":"Jones","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112685_bib23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1176\/appi.ajp.2019.18101217","article-title":"Prediction of onset of substance-induced psychotic disorder and its progression to Schizophrenia in a Swedish National Sample","volume":"176","author":"Kendler","year":"2019","journal-title":"AJP"},{"key":"10.1016\/j.drugalcdep.2025.112685_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drugalcdep.2017.02.006","article-title":"The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a US national sample","volume":"175","author":"Krawczyk","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112685_bib25","article-title":"Recent modifications to the US methadone treatment system are a Band-Aid\u2014not a solution\u2014to the nation\u2019s broken opioid use disorder treatment system","volume":"1","author":"Krawczyk","year":"2023","journal-title":"Health Aff. Sch."},{"key":"10.1016\/j.drugalcdep.2025.112685_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.05.031","article-title":"Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990\u20132014: a systematic review and meta-analysis","volume":"154","author":"Lai","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112685_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brat.2016.10.006","article-title":"Exclusion of participants based on substance use status: findings from randomized controlled trials of treatments for PTSD","volume":"89","author":"Leeman","year":"2017","journal-title":"Behav. Res. Ther."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112685_bib28","article-title":"US payment policy for medications to treat opioid use disorder: landscape and opportunities","volume":"2","author":"McGinty","year":"2024","journal-title":"Health Aff. Sch."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112685_bib29","article-title":"Alcohol use disorder and depressive disorders","volume":"40","author":"McHugh","year":"2019","journal-title":"Alcohol Res.: Curr. Rev."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112685_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamapsychiatry.2013.283","article-title":"Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study","volume":"70","author":"McKetin","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112685_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11414-011-9263-x","article-title":"Discrepancy in Diagnosis and Treatment of Post-traumatic Stress Disorder (PTSD): treatment for the Wrong Reason","volume":"39","author":"Meltzer","year":"2012","journal-title":"J. Behav. Health Serv. Res"},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112685_bib32","doi-asserted-by":"crossref","first-page":"40618","DOI":"10.4088\/JCP.21m14140","article-title":"Co-occurring depression and suicidal ideation in opioid use disorder: prevalence and response during treatment with buprenorphine-naloxone and injection naltrexone","volume":"83","author":"Na","year":"2022","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2025.112685_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109524","article-title":"Advances in the characterization of negative affect caused by acute and protracted opioid withdrawal using animal models","volume":"232","author":"Ozdemir","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2025.112685_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2016.06.010","article-title":"Organizing publicly funded substance use disorder treatment in the United States: moving toward a service system approach","volume":"69","author":"Padwa","year":"2016","journal-title":"J. Subst. Abus. Treat."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112685_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/1468-0009.00171","article-title":"Does medical insurance contribute to socioeconomic differentials in health?","volume":"78","author":"Ross","year":"2000","journal-title":"Milbank Q."},{"issue":"s1","key":"10.1016\/j.drugalcdep.2025.112685_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1360-0443.2006.01592.x","article-title":"Comorbidity between substance use disorders and psychiatric conditions","volume":"101","author":"Schuckit","year":"2006","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.drugalcdep.2025.112685_bib37","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/MLR.0000000000001107","article-title":"Revenue losses to state and federal government from opioid-related employment reductions","volume":"57","author":"Segel","year":"2019","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2025.112685_bib38","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112685_bib39","first-page":"337","article-title":"Methadone\u2019s resurgence in bridging the treatment gap in the overdose crisis: position statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction)","volume":"45","author":"Suen","year":"2024","journal-title":"Subst. Use amp; Addict. J."},{"key":"10.1016\/j.drugalcdep.2025.112685_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112636","article-title":"Assessing inequities in buprenorphine treatment across the care cascade","author":"Tilhou","year":"2025","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112685_bib41","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.0093","article-title":"Trends in engagement with opioid use disorder treatment among medicaid beneficiaries during the COVID-19 pandemic","volume":"3","author":"Tilhou","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112685_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/brainsci10020097","article-title":"Factors moderating the association between cannabis use and psychosis risk: a systematic review","volume":"10","author":"Van der Steur","year":"2020","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112685_bib43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biopsych.2019.07.027","article-title":"The negative affect of protracted opioid abstinence: progress and perspectives from rodent models","volume":"87","author":"Welsch","year":"2020","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112685_bib44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/JOM.0000000000001802","article-title":"Assessment of work loss associated with prescription-related opioid use disorder: a retrospective analysis of claims data","volume":"62","author":"White","year":"2020","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.drugalcdep.2025.112685_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.schres.2017.11.001","article-title":"Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: a systematic review","volume":"197","author":"Wilson","year":"2018","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.drugalcdep.2025.112685_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.11363","article-title":"Comparative effectiveness associated with buprenorphine and naltrexone in opioid use disorder and cooccurring polysubstance use","volume":"5","author":"Xu","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.drugalcdep.2025.112685_bib47","article-title":"Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: an analysis of insurance claims","volume":"9","author":"Xu","year":"2023","journal-title":"Drug Alcohol Depend. Rep."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112685_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13722-024-00450-0","article-title":"Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims","volume":"19","author":"Xu","year":"2024","journal-title":"Addict. Sci. Clin. Pr."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625001383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625001383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:04:48Z","timestamp":1774530288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871625001383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":48,"alternative-id":["S0376871625001383"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112685","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substance-induced mental disorders and discontinuation of medication for opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112685"}}